ABSTRACT
The present study was to identify the drug resistance, resistance mechanism and the extended-spectrum ß-lactamase (ESBLs) genotypes of Shigella flexneri (S. flexneri) in Jinan. Susceptibility tests were performed by MIC-determination. The genotypes of ß-lactamase were identified using PCR and DNA sequencing. The resistance transfer ability of the ESBL-producing strains was examined by conjugation tests. A total of 105 S. flexneri isolates were collected, and 34 (32.4%) were ESBL-producing isolates. All ESBL-producing isolates were susceptible to cefoxitin and imipenem, and 35.3% isolates were resistant to ciprofloxacin. ESBL-producing isolates showed high level resistant to ampicillin (100%), cefotaxime (100%), tetracycline (100%), chloramphenicol (100%), trimethoprim/sulfamethoxazole (100%), ceftazidime (73.5%) and cefepime (73.5%). Three types of ß-lactamase genes (blaTEM, blaOXA and blaCTX-M) were identified in all ESBL-producing isolates, and the genotypes were confirmed as blaTEM-1 (23/34), blaOXA-30 (34/34), blaCTX-M-14 (9/34) and blaCTX-M-15 (25/34) by sequencing. In conclusion, the Shigella strains isolated in Jinan are cross-resistant and multi-drug resistant. The main genotypes of ESBLs are CTX-M-14 and CTX-M-15.
Subject(s)
Drug Resistance, Multiple, Bacterial/genetics , Dysentery, Bacillary/drug therapy , Shigella flexneri/genetics , beta-Lactamases/genetics , Anti-Bacterial Agents/pharmacology , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/microbiology , Genotype , Humans , Microbial Sensitivity Tests , Shigella flexneri/classification , Shigella flexneri/pathogenicity , beta-Lactamases/classificationABSTRACT
Drug resistance to almost all antibiotics of Shigella flexneri, a major cause of shigellosis in developing countries, necessitates continuous discovery of novel therapeutics. This study reports a structure-function analysis of a potential drug target serine acetyltransferase (CysE), an enzyme of de novo cysteine biosynthesis pathway that is absent in humans. Analysis of CysE sequences of S. flexneri species and serotypes displayed only two variants that differed by a single amino acid substitution at position 241. Structural inspection of the available crystal structure disclosed this site to be distinct from the substrate/cofactor binding pockets or dimer/trimer interfaces. This study discovers that V241 variant of S. flexneri CysE has nearly null enzymatic activity. The observation is explained by molecular dynamic studies which reveal that the disorder generated by A241V substitution is the basis of dissociation of the quaternary assembly of S. flexneri CysE leading to loss of enzymatic activity and stability. The study provides the first evidence that position 241 of CysE, affects the catalytic efficiency of enzyme and suggests this locus as a 'hot spot' for the propagation of conformational changes. It may be postulated that transient quaternary structure of CysE maybe another mechanism for regulating the intracellular level of cysteine.
Subject(s)
Cysteine/biosynthesis , Dysentery, Bacillary/enzymology , Serine O-Acetyltransferase/chemistry , Shigella flexneri/enzymology , Amino Acid Sequence , Cloning, Molecular , Cysteine/genetics , Drug Resistance, Bacterial/genetics , Enzyme Stability , Escherichia coli/genetics , Humans , Molecular Dynamics Simulation , Mutation , Protein Structure, Quaternary , Serine O-Acetyltransferase/genetics , Shigella flexneri/genetics , Shigella flexneri/pathogenicityABSTRACT
Many bacterial pathogens hijack the host ubiquitin system for their own benefit by delivering effectors with ubiquitin ligase (E3) into host cells via the type III secretion system. Therefore, screening for small compounds that selectively inhibit bacterial but not mammalian E3 ligases is a promising strategy for identifying molecules that could substitute for antibiotics. To facilitate high-throughput screening for bacterial E3 ligase inhibitors, we developed a MiCy/mKO (Midori-ishi Cyan/monomeric Kusabira-Orange)-based FRET (fluorescence resonance energy transfer) assay and validated it on Shigella IpaH E3 ligase effectors. We showed the feasibility of using the MiCy/mKO-based FRET assay to identify the most appropriate ubiquitin-conjugating enzymes (E2s) and determine the lysine specificity of a given E3, both hallmarks of E3 activity. Furthermore, we showed the usefulness of the FRET assay in characterizing mammalian E3 ligases, such as TNF receptor-associated factor 6 (TRAF6) and mouse double minute 2 homologue (MDM2). In addition, we confirmed the feasibility of determining the efficiency of inhibition of E3 ligase activity using inhibitors of E1 ubiquitin-activating enzymes, such as UBE1-41, by measuring the IC50 . Based on these results, we concluded that the MiCy/mKO-based FRET assay is useful for characterizing E3 enzyme activity, as well as for high-throughput E3 inhibitor screening.
Subject(s)
Fluorescence Resonance Energy Transfer/methods , Green Fluorescent Proteins/analysis , Shigella flexneri/enzymology , Ubiquitin-Protein Ligases/chemistry , Animals , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/microbiology , High-Throughput Screening Assays , Humans , Inhibitory Concentration 50 , Luminescent Proteins/analysis , Lysine/metabolism , Mice , Ubiquitin-Protein Ligases/antagonists & inhibitors , Red Fluorescent ProteinABSTRACT
NF-κB plays a central role in modulating innate immune responses to bacterial infections. Therefore, many bacterial pathogens deploy multiple mechanisms to counteract NF-κB activation. The invasion of and subsequent replication of Shigella within epithelial cells is recognized by various pathogen recognition receptors as pathogen-associated molecular patterns. These receptors trigger innate defense mechanisms via the activation of the NF-κB signaling pathway. Here, we show the inhibition of the NF-κB activation by the delivery of the IpaH E3 ubiquitin ligase family member IpaH0722 using Shigella's type III secretion system. IpaH0722 dampens the acute inflammatory response by preferentially inhibiting the PKC-mediated activation of NF-κB by ubiquitinating TRAF2, a molecule downstream of PKC, and by promoting its proteasome-dependent degradation.
Subject(s)
Bacterial Proteins/metabolism , Dysentery, Bacillary/enzymology , Epithelial Cells/metabolism , NF-kappa B/metabolism , Protein Kinase C/metabolism , Proteolysis , Shigella/enzymology , TNF Receptor-Associated Factor 2/metabolism , Ubiquitin-Protein Ligases/metabolism , Animals , Bacterial Proteins/genetics , Bacterial Secretion Systems/genetics , COS Cells , Chlorocebus aethiops , Dysentery, Bacillary/genetics , Dysentery, Bacillary/pathology , Epithelial Cells/microbiology , Epithelial Cells/pathology , HeLa Cells , Humans , Mice , Mice, Knockout , NF-kappa B/genetics , Proteasome Endopeptidase Complex/genetics , Proteasome Endopeptidase Complex/metabolism , Protein Kinase C/genetics , Shigella/genetics , Signal Transduction/genetics , TNF Receptor-Associated Factor 2/genetics , Ubiquitin-Protein Ligases/genetics , Ubiquitination/geneticsABSTRACT
Shigella flexneri is a Gram-negative intracellular pathogen that infects the intestinal epithelium and utilizes actin-based motility to spread from cell to cell. S. flexneri actin-based motility has been characterized in various cell lines, but studies in intestinal cells are limited. Here we characterized S. flexneri actin-based motility in HT-29 intestinal cells. In agreement with studies conducted in various cell lines, we showed that S. flexneri relies on neural Wiskott-Aldrich Syndrome protein (N-WASP) in HT-29 cells. We tested the potential role of various tyrosine kinases involved in N-WASP activation and uncovered a previously unappreciated role for Bruton's tyrosine kinase (Btk) in actin tail formation in intestinal cells. We showed that Btk depletion led to a decrease in N-WASP phosphorylation which affected N-WASP recruitment to the bacterial surface, decreased the number of bacteria displaying actin-based motility, and ultimately affected the efficiency of spread from cell to cell. Finally, we showed that the levels of N-WASP phosphorylation and Btk expression were increased in response to infection, which suggests that S. flexneri infection not only triggers the production of proinflammatory factors as previously described but also manipulates cellular processes required for dissemination in intestinal cells.
Subject(s)
Dysentery, Bacillary/metabolism , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Protein-Tyrosine Kinases/metabolism , Shigella flexneri/metabolism , Actins/metabolism , Agammaglobulinaemia Tyrosine Kinase , Cell Line, Tumor , Cytosol/metabolism , Cytosol/microbiology , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/microbiology , HT29 Cells , Humans , Intestinal Mucosa/enzymology , Phosphorylation , Shigella flexneri/pathogenicity , Wiskott-Aldrich Syndrome Protein, Neuronal/metabolismABSTRACT
The phosphoinositide metabolic pathway, which regulates cellular processes implicated in survival, motility, and trafficking, is often subverted by bacterial pathogens. Shigella flexneri, a bacterium that causes dysentery, injects IpgD, a phosphoinositide phosphatase that generates the lipid phosphatidylinositol 5-phosphate (PI5P), into host cells, thereby activating the phosphoinositide 3-kinase-Akt survival pathway. We show that epidermal growth factor receptor (EGFR) is required for PI5P-dependent activation of Akt in infected HeLa cells or cells ectopically expressing IpgD. Cells treated with PI5P had increased numbers of early endosomes with activated EGFR, no detectable EGFR in the late endosomal or lysosomal compartments, and prolonged EGFR signaling. Endosomal recycling and retrograde pathways were spared, indicating that the effect of PI5P on the degradative route to the late endocytic compartments was specific. Thus, we identified PI5P, which was enriched in endosomes, as a regulator of vesicular trafficking that alters growth factor receptor signaling by impairing lysosomal degradation, a property used by S. flexneri to favor survival of host cells.
Subject(s)
Dysentery, Bacillary/enzymology , Endocytosis , ErbB Receptors/metabolism , Phosphatidylinositol Phosphates/metabolism , Shigella flexneri/enzymology , Signal Transduction , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Cell Survival , Dysentery, Bacillary/genetics , Endosomes/genetics , Endosomes/metabolism , Endosomes/microbiology , Enzyme Activation/genetics , ErbB Receptors/genetics , HeLa Cells , Humans , Lysosomes/genetics , Lysosomes/metabolism , Lysosomes/microbiology , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphatidylinositol Phosphates/genetics , Phosphoric Monoester Hydrolases/biosynthesis , Phosphoric Monoester Hydrolases/genetics , Protein Transport/genetics , Proteolysis , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Shigella flexneri/geneticsABSTRACT
The type III secretion system-dependent epithelial invasion and dissemination of Shigella is stimulated by ATP released through hemichannels. Romero et al. (2011) show that prior to epithelial contact, Shigella is captured by nanometer-thin micropodial extensions at a distance from the cell surface, in a process involving ATP and connexin-mediated signaling.
Subject(s)
Dysentery, Bacillary/microbiology , Epithelial Cells/microbiology , Host-Pathogen Interactions , Pseudopodia/microbiology , Shigella/physiology , Adenosine Triphosphate/metabolism , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/metabolism , Dysentery, Bacillary/physiopathology , Epithelial Cells/enzymology , Epithelial Cells/metabolism , Humans , Mitogen-Activated Protein Kinase 1/genetics , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/genetics , Mitogen-Activated Protein Kinase 3/metabolism , Pseudopodia/enzymology , Pseudopodia/metabolism , Shigella/geneticsABSTRACT
Shigella, the causative agent of bacillary dysentery in humans, invades epithelial cells, using a type III secretory system (T3SS) to inject bacterial effectors into host cells and remodel the actin cytoskeleton. ATP released through connexin hemichanels on the epithelial membrane stimulates Shigella invasion and dissemination in epithelial cells. Here, we show that prior to contact with the cell body, Shigella is captured by nanometer-thin micropodial extensions (NMEs) at a distance from the cell surface, in a process involving the T3SS tip complex proteins and stimulated by ATP- and connexin-mediated signaling. Upon bacterial contact, NMEs retract, bringing bacteria in contact with the cell body, where invasion occurs. ATP stimulates Erk1/2 activation, which controls actin retrograde flow in NMEs and their retraction. These findings reveal previously unappreciated facets of interaction of an invasive bacterium with host cells and a prominent role for Erk1/2 in the control of filopodial dynamics.
Subject(s)
Adenosine Triphosphate/metabolism , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/microbiology , Epithelial Cells/microbiology , Host-Pathogen Interactions , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Pseudopodia/microbiology , Shigella/physiology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cell Line , Dysentery, Bacillary/metabolism , Dysentery, Bacillary/physiopathology , Enzyme Activation , Epithelial Cells/enzymology , Epithelial Cells/metabolism , Humans , Mitogen-Activated Protein Kinase 1/genetics , Mitogen-Activated Protein Kinase 3/genetics , Pseudopodia/enzymology , Pseudopodia/metabolism , Shigella/genetics , Signal TransductionABSTRACT
The enteroinvasive bacterium Shigella flexneri uses multiple secreted effector proteins to downregulate interleukin-8 (IL-8) expression in infected epithelial cells. Yet, massive IL-8 secretion is observed in Shigellosis. Here we report a host mechanism of cell-cell communication that circumvents the effector proteins and strongly amplifies IL-8 expression during bacterial infection. By monitoring proinflammatory signals at the single-cell level, we found that the activation of the transcription factor NF-κB and the MAP kinases JNK, ERK, and p38 rapidly propagated from infected to uninfected adjacent cells, leading to IL-8 production by uninfected bystander cells. Bystander IL-8 production was also observed during Listeria monocytogenes and Salmonella typhimurium infection. This response could be triggered by recognition of peptidoglycan and is mediated by gap junctions. Thus, we have identified a mechanism of cell-cell communication that amplifies innate immunity against bacterial infection by rapidly spreading proinflammatory signals via gap junctions to yet uninfected cells.
Subject(s)
Dysentery, Bacillary/immunology , Immunity, Innate , MAP Kinase Signaling System/immunology , Mitogen-Activated Protein Kinases/immunology , NF-kappa B/immunology , Shigella flexneri/immunology , Caco-2 Cells , Cell Communication/immunology , Cell Proliferation , Dysentery, Bacillary/enzymology , Gap Junctions/immunology , Gap Junctions/microbiology , HeLa Cells , Humans , Interleukin-8/analysis , Interleukin-8/immunology , Listeria monocytogenes/immunology , Listeriosis/enzymology , Listeriosis/immunology , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Peptidoglycan/immunology , Shigella flexneri/enzymologyABSTRACT
As epidemic dysentery caused by Shigella dysenteriae type 1 is associated with high mortality, early identification of outbreaks is important. Since S. dysenteriae type 1 differs from most of the Enterobacteriaceae in that it does not produce catalase, a test for catalase may provide a useful screening method. The ability of a catalase test to provide rapid identification of S. dysenteriae type 1 has now been assessed, using isolates of this pathogen from five continents, Shigella of other species, and entero-invasive (EIEC) and Shiga-toxin-producing Escherichia coli (STEC). All of the isolates of S. dysenteriae type 1, as well as S. dysenteriae of types 3, 4, 6, 9, 11 and 12 and S. boydii of type 12, were found catalase-negative. All the other bacteria tested were positive for catalase. In an epidemic setting in South Africa, 406 xylose-negative and lysine-decarboxylase-negative isolates, collected from xylose-lysine-deoxycholate (XLD) agar, were tested for catalase. All 356 of the catalase-negative isolates were confirmed to be of S. dysenteriae type 1. None of the catalase-positive isolates were of S. dysenteriae type 1. The catalase test is useful in the rapid, presumptive identification of S. dysenteriae type 1, from appropriate culture media, because of its high predictive value, simplicity and speed. It would be particularly useful during dysentery outbreaks, when other Shigella would be uncommon. There was no association between the absence of catalase activity and the production of Shiga toxin.
Subject(s)
Catalase/analysis , Dysentery, Bacillary/diagnosis , Shigella/enzymology , Diagnostic Tests, Routine/methods , Disease Outbreaks , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/epidemiology , Humans , Population Surveillance/methods , Sensitivity and Specificity , Shigella dysenteriae/enzymology , South Africa/epidemiologyABSTRACT
Shigella flexneri is the causative agent of dysentery, and its pathogenesis is mediated by a type III secretion system (T3SS). S. flexneri secretes effector proteins into the eukaryotic cell via the T3SS, and these proteins usurp host cellular functions to the benefit of the bacteria. OspF and OspC1 are known to be secreted by S. flexneri, but their functions are unknown. We transformed S. flexneri with a plasmid that expresses a two-hemagglutinin tag (2HA) in frame with OspF or OspC1 and verified that these proteins are secreted in a T3SS-dependent manner. Immunofluorescence of HeLa cells infected with S. flexneri expressing OspF-2HA or OspC1-2HA revealed that both proteins localize in the nucleus and cytoplasm of host cells. To elucidate the function of these T3SS effectors, we constructed DeltaospF and DeltaospC1 deletion mutants by allelic exchange. We found that DeltaospF and DeltaospC1 mutants invade host cells and form plaques in confluent monolayers similar to wild-type S. flexneri. However, in the polymorphonuclear (PMN) cell migration assay, a decrease in neutrophil migration was observed for both mutants in comparison to the migration of wild-type bacteria. Moreover, infection of polarized T84 intestinal cells infected with DeltaospF and DeltaospC1 mutants resulted in decreased phosphorylation of extracellular signal-regulated kinase 1/2 in comparison to that of T84 cells infected with wild-type S. flexneri. To date, these are the first examples of T3SS effectors implicated in mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway activation. Ultimately, OspF and OspC1 are essential for PMN transepithelial migration, a phenotype associated with increased inflammation and bacterial access to the submucosa, which are fundamental aspects of S. flexneri pathogenesis.
Subject(s)
Bacterial Outer Membrane Proteins/metabolism , Dysentery, Bacillary , Intestinal Mucosa/microbiology , Neutrophils/microbiology , Shigella flexneri/pathogenicity , Virulence Factors/metabolism , Animals , Bacterial Outer Membrane Proteins/analysis , Bacterial Outer Membrane Proteins/genetics , Cell Movement , Cell Nucleus/chemistry , Cytoplasm/chemistry , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/immunology , Gene Deletion , Guinea Pigs , HeLa Cells , Humans , Macrophages/microbiology , Mitogen-Activated Protein Kinase 3/metabolism , Phosphorylation , Plasmids/genetics , Protein Transport , Virulence/genetics , Virulence Factors/analysis , Virulence Factors/geneticsABSTRACT
Bacteria of Shigella spp. are responsible for shigellosis in humans. They use a type III secretion system to inject effector proteins into host cells and induce their entry into epithelial cells or trigger apoptosis in macrophages. We present evidence that the effector OspG is a protein kinase that binds various ubiquitinylated ubiquitin-conjugating enzymes, including UbcH5, which belongs to the stem cell factor SCF(beta-TrCP) complex promoting ubiquitination of phosphorylated inhibitor of NF-kappaB type alpha (phospho-IkappaBalpha). Transfection experiments indicated that OspG can prevent phospho-IkappaBalpha degradation and NF-kappaB activation induced by TNF-alpha stimulation. Infection of epithelial cells by the S. flexneri wild-type strain, but not an ospG mutant, led to accumulation of phospho-IkappaBalpha, consistent with OspG inhibiting SCF(beta-TrCP) activity. Upon infection of ileal loops in rabbits, the ospG mutant induced a stronger inflammatory response than the wild-type strain. This finding indicates that OspG negatively controls the host innate response induced by S. flexneri upon invasion of the epithelium.
Subject(s)
Bacterial Proteins/metabolism , Dysentery, Bacillary/immunology , Dysentery, Bacillary/microbiology , Protein Kinases/metabolism , Shigella flexneri/enzymology , Shigella flexneri/pathogenicity , Ubiquitin-Conjugating Enzymes/antagonists & inhibitors , Animals , Bacterial Proteins/genetics , Cells, Cultured , Dysentery, Bacillary/enzymology , Humans , Ileum/microbiology , Ileum/pathology , Immunity, Innate , Intestinal Mucosa/microbiology , Iron-Binding Proteins/metabolism , Mutation , NF-kappa B/metabolism , Phosphorylation , Promoter Regions, Genetic , Protein Kinases/genetics , Rabbits , Shigella flexneri/genetics , Ubiquitin-Conjugating Enzymes/metabolismABSTRACT
Shigella flexneri is a Gram-negative pathogen that invades and causes inflammatory destruction of the human colonic epithelium, thus leading to bloody diarrhea and dysentery. A type III secretion system that delivers effector proteins into target eukaryotic cells is largely responsible for cell and tissue invasion. However, the respective role of this invasive phenotype and of lipid A, the endotoxin of the Shigella LPS, in eliciting the inflammatory cascade that leads to rupture and destruction of the epithelial barrier, was unknown. We investigated whether genetic detoxification of lipid A would cause significant alteration in pathogenicity. We showed that S. flexneri has two functional msbB genes, one carried by the chromosome (msbB1) and the other by the virulence plasmid (msbB2), the products of which act in complement to produce full acyl-oxy-acylation of the myristate at the 3' position of the lipid A glucosamine disaccharide. A mutant in which both the msbB1 and msbB2 genes have been inactivated was impaired in its capacity to cause TNF-alpha production by human monocytes and to cause rupture and inflammatory destruction of the epithelial barrier in the rabbit ligated intestinal loop model of shigellosis, indicating that lipid A plays a significant role in aggravating inflammation that eventually destroys the intestinal barrier. In addition, neutralization of TNF-alpha during invasion by the wild-type strain strongly impaired its ability to cause rupture and inflammatory destruction of the epithelial lining, thus indicating that TNF-alpha is a major effector of epithelial destruction by Shigella.
Subject(s)
Acyltransferases/genetics , Bacterial Proteins/genetics , Dysentery, Bacillary/microbiology , Dysentery, Bacillary/pathology , Escherichia coli Proteins , Genes, Bacterial , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Lipid A/metabolism , Shigella flexneri/genetics , Shigella flexneri/pathogenicity , Acylation , Animals , Caco-2 Cells , Disease Models, Animal , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/metabolism , Guinea Pigs , Humans , Intestinal Mucosa/immunology , Ligation , Monocytes/microbiology , Monocytes/pathology , Mutagenesis , Rabbits , Shigella flexneri/enzymology , Shigella flexneri/metabolism , Tumor Necrosis Factor-alpha/physiology , VirulenceABSTRACT
Shigella, the etiological agent of bacillary dysentery, rapidly kills human monocyte-derived macrophages in vitro. Wild-type Shigella flexneri, but not a nonvirulent derivative, induced human macrophage apoptosis as determined by morphology and terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL). Shigella-mediated macrophage cell death was blocked by the peptide inhibitors of caspases, acetyl-Tyr-Val-Ala-Asp-aldehyde (acetyl-YVAD-CHO) and acetyl-Tyr-Val-Ala-Asp-chloromethylketone (acetyl-YVAD-CMK). Protection from apoptosis by YVAD was observed in monocytes matured in the presence or absence of colony-stimulating factors (CSF) like macrophage-CSF or granulocyte-macrophage-CSF. Furthermore, lipopolysaccharide (LPS) or gamma interferon (IFN-gamma) rendered human macrophages partially resistant to Shigella cytotoxicity. Macrophages stimulated with either LPS or IFN-gamma were also protected by YVAD from Shigella-induced cell death. During Shigella infections of human macrophages, interleukin-1beta (IL-1beta) was cleaved to the mature form. IL-1beta maturation was severely retarded by YVAD, indicating that IL-1beta-converting enzyme (ICE; caspase 1) is activated in Shigella-induced apoptosis. The finding that Shigella induces apoptosis in human macrophages by activating ICE supports the hypothesis that the acute inflammation characteristic of shigellosis is initially triggered by apoptotic macrophages which release mature IL-1beta during programmed cell death.
Subject(s)
Apoptosis , Cysteine Endopeptidases/metabolism , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/pathology , Macrophages/microbiology , Shigella flexneri , Caspase 1 , Cells, Cultured , Humans , Interleukin-1/metabolism , Macrophages/enzymology , Macrophages/pathology , MonocytesABSTRACT
Immunohistochemical analysis was performed in 21 patients with acute and chronic dysentery, in 32 patients with different forms of salmonellosis in comparison with the cytoenzymatic status (CES) of immunocytes in the mucous membrane of the large intestine. It has been revealed that for acute dysentery the activation of the cellular and humoral links of local immunity is typical, but for salmonellosis--mainly of the humoral one. The chronic processes in dysentery and salmonellosis are connected with the increase in the subpopulation of T8-suppressors. Immunohistochemical data correlate completely with CES of immunocytes and that allows one use them with prognostic purposes.
Subject(s)
Dysentery, Bacillary/enzymology , Salmonella Infections/enzymology , Biopsy , Carrier State/enzymology , Carrier State/immunology , Dysentery, Bacillary/immunology , Humans , Immunity, Cellular/physiology , Immunoenzyme Techniques , Immunohistochemistry , Intestinal Mucosa/enzymology , Intestinal Mucosa/immunology , Intestinal Mucosa/pathology , Intestine, Large/enzymology , Intestine, Large/immunology , Intestine, Large/pathology , Lymphocytes/enzymology , Lymphocytes/immunology , Salmonella Infections/immunologyABSTRACT
Based on our previous findings we postulate that the production of blood group B-degrading mucinase by Shigella flexneri 2a is related to virulence. The virulent S. flexneri 2a strain M4243 produced a blood group B mucinase which decreased the blood group B reactivity of germ-free mouse mucins by a factor of 16 and the B reactivity of human saliva by a factor of 32. Avirulent S. flexneri 2a B-1, serologically similar, but not genetically identical to the M4243 strain, failed to degrade the blood group reactivity. The mucin-degrading ability of S. flexneri 2a M4243 harboring a large virulence-conferring 140 MDa plasmid was then compared with a genetically similar large plasmid-free avirulent S. flexneri 2a M4243A1. Virulent S. flexneri M4243 grew in human salivary mucins while the genetically identical avirulent M4243A1 did not. Supernatant of virulent M4243 culture decreased the blood B reactivity of salivary mucins by a factor of 32 while the avirulent M4243a1 had no effect. Eleven of 12 colonies of the transconjugant hybrid Escherichia coli K12 (7300-1-5) containing the shigella PWR 110 plasmid and chromosomal markers decreased the blood group B reactivity by a factor of 4-32, and two of four colonies of the E. coli strain 7262 containing only the plasmid reduced the B reactivity by a factor of 4-16. These findings suggest that blood group B-specific mucinase production may be related to S. flexneri virulence.
Subject(s)
Dysentery, Bacillary/genetics , Gene Expression Regulation, Bacterial , Plasmids/genetics , Shigella flexneri/genetics , Virulence/genetics , ABO Blood-Group System , Dysentery, Bacillary/enzymology , Escherichia coli/genetics , Hybridization, Genetic , Mucins/metabolism , Polysaccharide-Lyases/metabolism , Serotyping , Shigella flexneri/enzymology , Shigella flexneri/pathogenicity , Virulence/physiologyABSTRACT
Cytoenzymatic and morphological methods were used to reveal local and general immunity disorders in patients with lingering and chronic dysentery. In this connection the therapeutic effect of the immunomodulator T-activin was estimated. 51 patients with the above forms of dysentery were examined. The patients were distributed into basic groups given T-activin and control groups not on the drug. The function of immune cells was evaluated by the enzymic status--the ratio of the activity of the following enzymes: succinate and glycerophosphate dehydrogenases, NADP and acid phosphatase. One of the causes of chronic dysentery was functional deficiency of lymphoid and phagocytizing cells of the colonic mucosa, supported by the data on their enzymic status. Analogous deficiency was discovered in peripheral blood leukocytes. T-activin successfully corrects the revealed immune disorders, stimulates metabolic processes in the cells and reduces inflammation and ameliorates the repair of the intestinal mucosa as well.
Subject(s)
Adjuvants, Immunologic/therapeutic use , Dysentery, Bacillary/drug therapy , Lymphocytes/drug effects , Oxidoreductases/drug effects , Peptides/therapeutic use , Thymus Extracts/therapeutic use , Biopsy , Drug Evaluation , Dysentery, Bacillary/enzymology , Dysentery, Bacillary/immunology , Dysentery, Bacillary/pathology , Histocytochemistry , Humans , Intestinal Mucosa/drug effects , Intestinal Mucosa/enzymology , Intestinal Mucosa/immunology , Intestinal Mucosa/ultrastructure , Intestine, Large/drug effects , Intestine, Large/enzymology , Intestine, Large/immunology , Intestine, Large/ultrastructure , Lymphocytes/enzymology , Lymphocytes/immunology , Lymphocytes/ultrastructure , Microscopy, Electron , Oxidoreductases/metabolismABSTRACT
The effect of S. flexneri virulent and avirulent (vaccine) strains 2a on the cytoplasmic membrane of mouse macrophages has been studied by evaluating the action of these bacteria on the activity of 5-nucleotidase. The dynamics of the activity of 5-nucleotidase after the introduction of both virulent and avirulent strains has a phasic character with alternating rises and falls in the activity of this enzyme in comparison with the control. S. flexneri vaccine strain produces mainly a stimulating effect on the functional activity of peritoneal macrophages in mice, which is confirmed by a decrease in the activity of 5-nucleotidase; on the contrary, S. flexneri virulent strain- has mainly an inhibiting effect on the functional activity of peritoneal macrophages, which is confirmed by an increase in the activity of 5-nucleotidase in these cells. The comparative study of changes in the activity of 5-nucleotidase, following the introduction of S. flexneri, in mice, previously immunized with smallpox vaccine, and in intact mice has shown that the use of animals immunized with smallpox vaccine in the study of metabolic characteristics may lead to distortions in the results of the experiment.
Subject(s)
Dysentery, Bacillary/enzymology , Macrophages/enzymology , 5'-Nucleotidase , Animals , Ascitic Fluid/enzymology , Cell Membrane/enzymology , Immunization , Male , Mice , Nucleotidases/metabolism , Shigella flexneri/pathogenicity , Smallpox Vaccine/immunology , Time Factors , VirulenceABSTRACT
The overtime study of changes in the activity of cathepsin D, a lysosomal enzyme, in the splenocytes of CBA mice after their infection with virulent and avirulent Shigella strains of the same origin and with the same antigenic structure has been made. As the result of two months of observations, changes in the activity of this enzyme in the cytoplasmic and lysosomal cell fractions have been found to occur in phases. The activity of cathepsin D has been shown to depend on the virulence of Shigella strains used for inoculation. Virulent Shigella strains induce the pronounced and prolonged activation of the enzyme in the lysosomes, as well as in the cytoplasm. The latter phenomenon is probably indicative of the pathological labilization of the lysosomal membranes, induced by the virulent culture. Avirulent Shigella strains induce only the transient activity of the enzyme in the lysosomes without any essential changes in the permeability of their membranes. These data point to the possibility of differentiating virulent and avirulent Shigella strains by the determination of the enzymatic activity of splenocytes in infected animals.
Subject(s)
Cathepsin D/metabolism , Shigella flexneri/pathogenicity , Shigella sonnei/pathogenicity , Spleen/enzymology , Animals , Cytoplasm/enzymology , Dysentery, Bacillary/enzymology , Enzyme Activation , Lysosomes/enzymology , Mice , Mice, Inbred CBA , Time Factors , VirulenceABSTRACT
To investigate the pathogenesis of diarrhea in ulcerative colitis, colonic adenylate cyclase activity was determined in patients and normal subjects. Basal adenylate cyclase activity in 19 patients with active disease [61.5 +/- 9.6 (mean +/- SE) pmol cyclic adenosine monophosphate/mg protein . 10 min] was two times higher (p less than 0.01) than its activity in colonic mucosa of 30 normal subjects or 10 ulcerative colitis patients in remission [31.4 +/- 2.0 and 23.6 +/- 1.9 pmol cyclic adenosine monophosphate/mg protein . 10 min, respectively]. The enzyme activity was stimulated to the same extent in all groups by sodium fluoride, vasoactive intestinal polypeptide, or by substitution in the assay mixture of guanosine triphosphate by its hydrolysis-resistant analogue--GTP gamma S. Prostaglandin E2 significantly stimulated the enzyme activity in tissue obtained from normal subjects, patients with shigellosis, and ulcerative colitis patients in remission while it had no effect on adenylate cyclase activity in colonic mucosa of patients with active ulcerative colitis. These results suggest that stimulation of colonic adenylate cyclase activity, possibly secondary to the reported enhanced colonic prostanoid synthesis, may contribute to the diarrhea in ulcerative colitis.